MedTrace Logo

Cancer Prevention for Young Rural Adults

NCT05618158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1796

Last updated 2025-12-26

No results posted yet for this study

Summary

Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy eating, nicotine produce us, heavy drinking of alcohol, increased UV exposure, and incomplete uptake of HPV vaccination. A multi-risk factor campaign will be developed to reduce these cancer risk behaviors and delivered to young adults over social media, a popular channel that can reach nearly all young adults. The campaign will be evaluated for effectiveness in a rigorous randomized trial with measures of moderate to vigorous physical activity, healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination uptake.

Conditions

Interventions

BEHAVIORAL

4 Corners Rural Health Cancer Prevention

Participants, aged 18-26, will join a private Facebook group to participate in the intervention. The group is not viewable to the public, including other Facebook users. Content that focuses on cancer prevention behaviors will be posted twice per day for up to 12 months. Each group will be hosted by a moderator who is responsible for managing the intervention goals and participants' engagement.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Arizona

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Colorado State University

    collaborator OTHER

  • University of Colorado, Denver

    collaborator OTHER

  • University of New Mexico

    collaborator OTHER

  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • David Buller, PhD · Klein Buendel, Inc.

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-20
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618158 on ClinicalTrials.gov